Stocks
Sarepta Therapeutics (SRPT) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.84 | 1.64 | 2.37 | 0.79 | 1.04 | 0.15 | |||
| Changes by years, y/y, % | -62% | +94% | +45% | -67% | +33% | -13.8% | |||
Sarepta Therapeutics. Debt/EBITDA
Sarepta Therapeutics. Debt/EBITDA, changes, %
Sarepta Therapeutics (SRPT) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 1.18 | 1.23 | 1.30 | 1.24 | 0.15 | 0.15 | ||
| Changes by years, y/y, % | -66% | -38% | +28% | +58% | -87% | |||
| Changes by quarters, q/q, % | +50% | +4% | +6% | -5% | -88% | |||
